Delivered-To: edward.couch@gmail.com
Received: by 10.194.76.34 with SMTP id h2csp79675wjw;
        Wed, 17 Apr 2013 19:41:01 -0700 (PDT)
Return-Path: <alexrives@gmail.com>
Received-SPF: pass (google.com: domain of alexrives@gmail.com designates 10.49.0.67 as permitted sender) client-ip=10.49.0.67
Authentication-Results: mr.google.com;
       spf=pass (google.com: domain of alexrives@gmail.com designates 10.49.0.67 as permitted sender) smtp.mail=alexrives@gmail.com;
       dkim=pass header.i=@gmail.com
X-Received: from mr.google.com ([10.49.0.67])
        by 10.49.0.67 with SMTP id 3mr10079701qec.9.1366252860666 (num_hops = 1);
        Wed, 17 Apr 2013 19:41:00 -0700 (PDT)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=gmail.com; s=20120113;
        h=mime-version:x-received:date:message-id:subject:from:to
         :content-type;
        bh=BqhK+dZ4QMSJLPaXRqGGacGMlcpGV2gz2UGUj0xUZq8=;
        b=CupVgA6wb6G3vsqlWFrH9QYmUlv8vZgp9CuC8v8yKlUtcEN0xc3RuljBNt0AuRzWuc
         VfCrSYP+89CYPiUjArKJEPNFsDDzAmnrFw1ud6NTHaP9z4WhIqs6t6K3QXw07Mv8udnZ
         mbSTErz4yrKmpolw+0Ntl0Kuw/Weay+E+w5/+71fvXYcuNT62w/BBfdvHbL8FNlPIEGY
         44QUJH9OGskrPKFmCPVQJbirtFqa6F5aJGl6rNok0q3kxHJb+Huob9SFDSVwPK2UFaAT
         YRw3+JmiSFxvArzya6nIDkvzp2UR9qD5tUW446x5yQdZcseVgriqdRLzWed6f8mdEILe
         CX0w==
MIME-Version: 1.0
X-Received: by 10.49.0.67 with SMTP id 3mr10079701qec.9.1366252860661; Wed, 17
 Apr 2013 19:41:00 -0700 (PDT)
Received: by 10.229.207.137 with HTTP; Wed, 17 Apr 2013 19:41:00 -0700 (PDT)
Date: Wed, 17 Apr 2013 22:41:00 -0400
Message-ID: <CANxdgOe+qOO_jmJUQzEbOLgyKjb73UnMJeanXwRha2rjTVMYXg@mail.gmail.com>
Subject: ALKS 5461
From: Alexander Rives <alexrives@gmail.com>
To: Edward Couch <edward.couch@gmail.com>
Content-Type: multipart/alternative; boundary=047d7b33d2146ee66404da998802

--047d7b33d2146ee66404da998802
Content-Type: text/plain; charset=ISO-8859-1

This looks like a very interesting drug. Detailed results will be released
at the end of May.

http://investor.alkermes.com/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=1807510

--047d7b33d2146ee66404da998802
Content-Type: text/html; charset=ISO-8859-1
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr"><div style>This looks like a very interesting drug. Detail=
ed results will be released at the end of May.</div><div><br></div><a href=
=3D"http://investor.alkermes.com/phoenix.zhtml?c=3D92211&amp;p=3Dirol-newsA=
rticle&amp;ID=3D1807510">http://investor.alkermes.com/phoenix.zhtml?c=3D922=
11&amp;p=3Dirol-newsArticle&amp;ID=3D1807510</a><br>
</div>

--047d7b33d2146ee66404da998802--
